06/26/2025
Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, and rising international competition.
If we do not act to strengthen the United States’ biotech sector, we risk surrendering our global leadership to countries like China, which are aggressively scaling biotech industries without the same standards for safety and data accuracy.
CLICK HERE to read Dr. Gabi Hanna’s full opinion column in Crain’s Cleveland Business.